Provided by Tiger Trade Technology Pte. Ltd.

Genenta Science S.p.A.

0.9850
-0.0250-2.48%
Volume:13.67K
Turnover:13.62K
Market Cap:23.24M
PE:-2.53
High:1.03
Open:1.02
Low:0.9700
Close:1.01
52wk High:10.00
52wk Low:0.5500
Shares:23.59M
Float Shares:13.87M
Volume Ratio:0.37
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3890
EPS(LYR):-0.3890
ROE:-38.03%
ROA:-17.67%
PB:0.92
PE(LYR):-2.53

Loading ...

Genenta Holds 19.9% Stake in Italy’s Sòphia High Tech, with Option to Lift to 51%

Reuters
·
Yesterday

ADRs Advance; Arm Holdings PLC Climbs 17%

Dow Jones
·
Aug 05

Genenta Science Announces Extraordinary Shareholders Meeting Reconvened for Sept. 10-11

Reuters
·
Aug 01

Sophia unveils Roman robotic arm to inspect nuclear fusion machine operations

TIPRANKS
·
Jul 23

Genenta-backed Sòphia High Tech Unveils ROMAN Robotic Arm for Nuclear Fusion Reactor Maintenance

Reuters
·
Jul 23

Genenta-backed Sophia High Tech Names New Board Led by CEO Antonio Caraviello

Reuters
·
Jul 22

Press Release: Genenta-backed Sòphia High Tech Reports Fiscal Year 2025 Results

Dow Jones
·
Jul 22

Milan Court Lifts Suspension of Genenta Corporate Purpose Amendment in Shareholder Suit

Reuters
·
Jul 15

Genenta Delays Extraordinary Shareholder Meeting to July 29-30

Reuters
·
Jul 02

Milan Court Suspends Genenta Corporate-purpose Amendment Pending Proceedings

Reuters
·
Jun 27

Genenta regains Nasdaq compliance with $1 minimum bid price rule

Reuters
·
Jun 16

Top Premarket Gainers

MT Newswires Live
·
Jun 01

Genenta Science completes acquisition of remaining 80.5% stake in A.T.C. for EUR 9.6 million

Reuters
·
May 30

Genenta Science shifts focus to building industrial aggregator in Italy and Europe

Reuters
·
Apr 29

Genenta to invest EUR 6 million for 19.9% stake in Sophia High Tech

Reuters
·
Apr 23

Genenta gets Nasdaq notice after shares trade below $1 minimum bid price

Reuters
·
Apr 15

Genenta net loss narrows 27% to €6.5 million in FY25

Reuters
·
Apr 01

Genenta signs binding offer to acquire stake in Sòphia High Tech; funding totals EUR 6 million in two tranches

Reuters
·
Mar 27

Genenta files initial beneficial ownership statement; Director Giacomoantonio Paracchi reports 0 ADSs

Reuters
·
Mar 26

Genenta continues to evaluate options for original biotechnology platform

TIPRANKS
·
Mar 24